Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

FSU Health Communication expert finds GLP-1 users face stigma within their social circles

Дата публикации: 24-09-2026 12:00:35

People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, according […]
The post FSU Health Communication expert finds GLP-1 users face stigma within their social circles appeared first on Florida State University News.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Florida State University expert explores potential GLP-1 link to binge-eating improvements015.218-08-2026
2Weight loss drugs may literally be saving people's arms and legs5706-07-2026
3Unexpected GLP-1 side effect? Studies show the meds may help people with addictions08.2123-08-2026
4Beyond the Jab: The Surprising New Frontiers of GLP-1 Therapy014.1324-07-2026
5Number of Americans taking GLP-1s for weight loss hits record high: Survey0707-07-2026
6Compounded GLP-1 drugs creating concern among doctors and FDA06.7527-07-2026
7Compounded GLP-1 drugs creating concern among doctors and FDA06.7527-07-2026
8‘A new consumer’: how weight-loss drugs are shaking up clothes shopping5711-07-2026
9Doctor reveals how to maintain new physique after reaching weight-loss goal on Ozempic... and what to do if progress stalls08.7623-02-2026
10GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you’re covered0718-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.32. Источник: news.fsu.edu.